Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Case Rep Hematol ; 2023: 1381861, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37529087

RESUMO

Background: Mixed warm/cold autoimmune hemolytic anemia (AIHA) is a rare diagnostic entity with limited therapeutic options. Previous literature has described the diagnostic difficulty in this pathology and the limited response rates to corticosteroids. Furthermore, there is limited evidence regarding the use of rituximab in this condition. Methods: Alongside our case report, we conducted a scoping review of case reports/case series describing mixed AIHA, their treatment, and clinical outcomes since 2000. Inclusion criteria included a confirmed diagnosis of mixed AIHA (confirmed warm antibodies and cold agglutinins based on DAT). Case Summary/Results. We present a case of mixed AIHA in an 83-year-old female presenting with extensive, bilateral pulmonary embolisms and left renal vein thrombosis. The patient underwent extensive workup with no identifiable provoking etiology. Initial treatment involved prednisone therapy was transitioned to rituximab upon diagnosis of mixed AIHA. The patient demonstrated a mixed response with stable hemoglobin and transfusion independence; however, with persistently elevated hemolytic indices following completion of rituximab treatment. Our literature review identified 16 articles; two were excluded for unavailable clinical details. The most commonly associated conditions included autoimmune conditions (n = 5, 26%) and lymphoproliferative disorders (n = 3, 12%). The most common treatment involved corticosteroids; seven studies involved the use of rituximab. Conclusion: Mixed AIHA represents a complex diagnosis and optimal management is not well established. Consistent with our case, recent literature suggests a promising response to rituximab and a limited response to steroid treatment. Given the limited literature, additional studies are required to elucidate optimal management of this unique pathology.

2.
Support Care Cancer ; 29(9): 5273-5281, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33651181

RESUMO

OBJECTIVE: Cancer patients may turn to social media (SM) to cope with distress. We investigated associations between distress and internet/SM use for cancer information/support. METHODS: Adult patients at a Canadian cancer centre completed a cross-sectional survey on sociodemographics, health status, use of cancer online resources and distress (EQ5D-5L). Statistical models adjusted for relevant variables. RESULTS: Of 376 participants, median age was 52 years, time since diagnosis was 1.63 years, 272 (74%) had post-secondary education and 192 (51%) were female. For cancer information/support, 276 (73%) used internet and 147 (39%) SM. Dose response relationships were observed between distress and cancer-related internet (p = 0.02), and SM use (p < 0.001). Respondents using internet/SM for cancer information/support reported greater internet confidence (internet OR = 4.0, 95% CI: 1.9-8.3; SM OR = 4.18, 95%, CI: 1.9-11.3), higher education (internet OR = 3.0, 95% CI: 1.7-5.2; SM OR = 2.21, 95% CI: 1.2-4.1) and were more likely female (internet OR = 2.6, 95% CI 1.5-4.6; SM OR = 2.1, 95% CI: 1.3-3.4). For SM for cancer information/support, more used SM > 30 min daily (OR = 3.4; 95% CI: 2.1-5.7), and were distressed (OR = 1.67, 95% CI: 1.0-2.7). SM benefits were to learn about cancer (93; 25%), distract from cancer (85; 23%) and connect with survivors (81; 22%). SM limitations were privacy (161; 43%), quality (90; 24%) and personal applicability (85; 23%). Females used SM more to connect with survivors than males (p = 0.001). CONCLUSIONS: Greater internet confidence, higher education and being female were associated with cancer-related internet/SM use. Distressed cancer patients were also more likely to turn to SM. Privacy concerns may limit SM use for coping. Future research should determine how to optimize SM in caring for and connecting with patients and reduce cancer-related distress.


Assuntos
Neoplasias , Mídias Sociais , Canadá , Sobreviventes de Câncer , Estudos Transversais , Feminino , Humanos , Internet , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários
3.
Sci Total Environ ; 733: 138802, 2020 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-32447075

RESUMO

Samples of beached plastics and historical and contemporary consumer plastics containing hazardous elements derived from reaction residues or functional additives have been micronised and subject to extraction conditions representative of the digestive environment of seabirds. Mobilisation of Br, Cd, Cr, Hg, Pb and Sb into NaCl solution, an avian physiologically-based extraction test (PBET) and a dietary-adapted PBET (DA-PBET) incorporating fish oil as part of the avian diet was monitored by ICP-MS over a 168-h period. Kinetic data were subsequently fitted using pseudo-first-order and parabolic diffusion models in order to derive rate constants for the release of hazardous elements during avian digestion of microplastics. Rate constants were variable and dependent on the nature and origin of plastic, type of residue or additive, extractant solution employed and model applied. Resulting estimates of bioaccessibility, defined as the equilibrium or maximum concentration of an element mobilised over the time course relative to its total concentration, were variable but considerable in many cases. Specifically, maximum values of about 65% of Cd and 100% of Pb were observed in consumer polycarbonate-acrylonitrile butadiene styrene exposed to the avian PBET and beached polyurethane exposed to the DA-PBET, respectively. The potential health risks of hazardous elements in microplastics are addressed and criteria for classification based on the European Toy Safety Directive migration (mobilisation) limits are proposed.


Assuntos
Mercúrio , Plásticos , Animais , Aves , Cádmio , Dieta , Cinética , Chumbo , Microplásticos
4.
J Geriatr Oncol ; 11(6): 1011-1019, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32169545

RESUMO

OBJECTIVES: The internet and social media provide information and support to cancer survivors, and adolescent and young adults (AYA, age < 40 years), adults, and older (age 65+ years) cancer survivors may have different needs. We evaluated the impact of age on cancer-related internet and social media use and confidence in evaluating online information for cancer-care decision making. MATERIALS AND METHODS: Cancer survivors completed a convenience cross-sectional survey evaluating their cancer-related internet and social media use and their confidence in using these resources for decision making. Multivariable regression models evaluated the impact of age on usage patterns and confidence. RESULTS: Among 371 cancer survivors, 58 were older adults and 138 were AYA; 74% used the internet and 39% social media for cancer care; 48% felt confident in using online information for cancer-care decisions. Compared to adult survivors, there was a non-significant trend for older survivors to be less likely to use the internet for cancer-care information(aOR = 0.49, 95% CI[0.23-1.03], P = .06), while AYA were more likely to use social media for cancer-care (aOR = 1.79[1.08-2.99], P = .03). Although confidence at using online information for cancer-care decision making did not differ between age groups, increasing age had a non-significant trend towards reduced confidence (aOR = 0.99 per year [0.97-1.00], P = .09). Most commonly researched and desired online information were causes/risk factors/symptoms, treatment options, and prognosis/outcomes. CONCLUSIONS: Age may influence the use of internet and social media for cancer-care, and older cancer survivors may be less confident at evaluating online information for cancer-care decision making. Future research should explore other strategies at meeting the informational needs of older cancer survivors.


Assuntos
Sobreviventes de Câncer , Internet , Neoplasias , Mídias Sociais , Adolescente , Idoso , Estudos Transversais , Humanos , Neoplasias/terapia , Inquéritos e Questionários , Sobreviventes , Interface Usuário-Computador
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...